Trisk Bio

Custom AAV Manufacturing

London · Founded 2020 · $16.6M raised

Headquarters
London
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$16.6M
Last Round
$2.0M SeedDec 2021
Rounds
2

About

Trisk Bio is a London-based contract manufacturer specializing in custom AAV (adeno-associated virus) production for gene therapy developers, offering fully scalable preclinical manufacturing processes from 1e13 vg research-grade batches up to 5e13–1e15 vg for non-human-primate-grade studies. The company develops bespoke, forecastable production processes across all capsid serotypes and transgenes, including high-throughput process optimization and analytical development, to make preclinical AAV manufacturing faster and more affordable. Trisk Bio has partnered with organizations including Dyno Therapeutics and NanoMosaic to expand its capsid engineering and AAV analytics capabilities.

Summary

Trisk Bio is a Biotech company based in London, founded in 2020. It has raised $16.6M in total across 2 rounds, most recently a $2.0M Seed round in Dec 2021. Investors include Matrix Partners and Quiet Capital.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2021
$2.0M

Sign up to see all 2 rounds

Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trisk Bio on Indexed.vc
<a href="https://indexed.vc/companies/trisk-bio"><img src="https://indexed.vc/api/badge/company/trisk-bio" alt="Trisk Bio on Indexed.vc" width="260" height="76" /></a>